Bruker Corporation (BRKR) is a publicly traded Healthcare sector company. As of October 13, 2026, BRKR trades at $56.50 with a market cap of $8.96B and a P/E ratio of -85.33. BRKR moved +0.44% today. Year to date, BRKR is +19.40%; over the trailing twelve months it is +59.44%. Its 52-week range spans $28.53 to $66.98. Analyst consensus is buy with an average price target of $61.11. Rallies surfaces BRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BRKR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $56.50 |
| Market Cap | $8.96B |
| P/E Ratio | -85.33 |
| EPS | $-0.70 |
| Dividend Yield | 0.05% |
| 52-Week High | $66.98 |
| 52-Week Low | $28.53 |
| Volume | 107 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.50B |
| Net Income | $-64.50M |
| Gross Margin | 46.42% |
10 analysts cover BRKR: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $61.11.